Earnings History Data for Acurx Pharmaceuticals, Inc. (ACXP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. It focused on developing new antibiotics to treat infections. Acurx Pharmaceuticals Inc. is based in STATEN ISLAND, N.Y.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
09-08-2024 | PM | ACXP | Acurx Pharmaceuticals, Inc. | 31.13 | -0.26 | -0.28 | -0.28 | Acurx Pharmaceuticals GAAP EPS of -$0.26 misses by $0.04 [8/9/2024 7:07 AM] |
1.87 | -0.03 (-1.39%) |
2.02 | 0.12 (6.32%) |
1.17 - 8.82 | 50,193 | 40,000 | 1,864 | ||
14-05-2024 | PM | ACXP | Acurx Pharmaceuticals, Inc. | 31.99 | -0.28 | -0.24 | -0.25 | Acurx Pharmaceuticals GAAP EPS of -$0.28 misses by $0.04 [5/15/2024 6:51 AM] |
2.23 | 0.14 (6.70%) |
2.33 | 0.24 (11.48%) |
1.17 - 8.82 | 147,108 | 40,000 | 21,561 | ||
13-11-2023 | PM | ACXP | Acurx Pharmaceuticals, Inc. | 50.07 | -0.24 | -0.28 | -0.32 | Acurx Pharmaceuticals GAAP EPS of -$0.24 [11/14/2023 7:23 AM] |
3.39 | -0.11 (-3.11%) |
3.45 | -0.05 (-1.43%) |
1.17 - 8.82 | 131,692 | 530,000 | 12,240 | ||
14-08-2023 | PM | ACXP | Acurx Pharmaceuticals, Inc. | 21.13 | -0.28 | -0.29 | -0.26 | Acurx Pharmaceuticals GAAP EPS of -$0.28 misses by $0.07 [8/14/2023 7:25 AM] |
1.67 | -0.15 (-8.40%) |
0.0 | 0.0 (0.00%) |
1.61 - 4.68 | 49,371 | 40,000 | 0 | ||
12-05-2023 | PM | 7:00 AM ET (May 12) |
ACXP | Acurx Pharmaceuticals | 38.00 | -0.25 | -0.34 | 0.00 | Acurx Pharmaceuticals GAAP EPS of -$0.25 [5/12/2023 7:02 AM] |
3.03 | -0.28 (-8.46%) |
0.0 | 0.0 (0.00%) |
2.33 - 4.85 | 10,881 | 30,000 | 0 | |
16-03-2023 | PM | 7:00 AM ET (Mar 16) |
ACXP | Acurx Pharmaceuticals, Inc. | 37.10 | -0.28 | -0.25 | -0.23 | Acurx Pharmaceuticals GAAP EPS of -$0.28 beats by $0.15 [3/16/2023 7:10 AM] |
3.22 | -0.19 (-5.57%) |
3.65 | 0.24 (7.04%) |
2.33 - 4.85 | 56,838 | 40,000 | 600 | |
14-11-2022 | PM | Before the open (Nov 14) |
ACXP | Acurx Pharmaceuticals, Inc. | 33.05 | -0.32 | 0.00 | -0.46 | Acurx Pharmaceuticals GAAP EPS of -$0.32 misses by $0.04 [11/14/2022 7:07 AM] |
3.29 | 0.38 (13.22%) |
0.0 | 0.0 (0.00%) |
2.33 - 5.50 | 35,287 | 30,000 | 0 | |
15-08-2022 | PM | Before the open (Aug 16) |
ACXP | Acurx Pharmaceuticals, Inc. | 37.05 | -0.26 | 0.00 | -0.57 | Acurx Pharmaceuticals GAAP EPS of -$0.26 [8/15/2022 8:19 AM] |
4.42 | -0.09 (-2.00%) |
0.0 | 0.0 (0.00%) |
2.33 - 5.92 | 33,852 | 50,000 | 0 | |
11-05-2022 | PM | Before the open (May 11) |
ACXP | Acurx Pharmaceuticals, Inc. | 35.92 | -0.26 | 0.00 | 0.00 | Acurx Pharmaceuticals GAAP EPS of -$0.26 beats by $0.07 [5/11/2022 7:15 AM] |
3.31 | -0.14 (-4.06%) |
0.0 | 0.0 (0.00%) |
3.09 - 8.74 | 12,129 | 20,000 | 0 | |
17-03-2022 | PM | Before the open (Mar 17) |
ACXP | Acurx Pharmaceuticals, Inc. | 38.10 | -0.23 | 0.00 | 0.00 | Acurx Pharmaceuticals GAAP EPS of -$1.49 beats by $0.20 [3/17/2022 7:30 AM] |
3.87 | 0.15 (4.03%) |
3.72 | 0.0 (0.00%) |
3.09 - 8.74 | 48,768 | 29,785 | 1,400 | |
|
||||||||||||||||||
12-11-2021 | PM | Before the open (Nov 15) |
ACXP | Acurx Pharmaceuticals, Inc. | 50.49 | -0.46 | 0.00 | 0.00 | Acurx Pharmaceuticals reports Q3 results [11/15/2021 2:01 AM] |
4.88 | -0.09 (-1.84%) |
4.60 | -0.37 (-7.38%) |
3.71 - 8.74 | 38,470 | 60,000 | 3,000 | |
16-08-2021 | PM | Before the open (Aug 17) |
ACXP | Acurx Pharmaceuticals, Inc. | 47.60 | -0.57 | 0.00 | 0.00 | Acurx Pharmaceuticals reports Q2 results [8/16/2021 10:57 AM] |
3.76 | -0.47 (-11.06%) |
4.04 | -0.19 (-4.49%) |
3.71 - 8.74 | 181,024 | 120,000 | 4,962 | |
|